Benzinga | Oct 28, 2020 06:23AM EDT

SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $160

SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $115 to $160.